| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/06/2007 | US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders |
| 09/06/2007 | US20070208045 Substituted-(quinazolinyl)phenyl thiophenyl-sulfonylureas, methods for making and intermediates thereof |
| 09/06/2007 | US20070208044 Compounds and therapeutical use thereof |
| 09/06/2007 | US20070208043 Gene expression inhibition; p38 map kinase inhibitors |
| 09/06/2007 | US20070208042 Method of using vasoconstrictive agents during energy-based tissue therapy |
| 09/06/2007 | US20070208041 Compositions for the treatment and prevention of heart disease and methods of using same |
| 09/06/2007 | US20070208040 e.g. 3-ethyl-5-methyl-1,3-dihydrothiopheno[2,3-d]pyrimidine-2,4-dione; neurodegenerative disorders, antiischemic agent, antidepressant, attention deficit disorder, hepatic fibrosis, cirrhosis of the liver, and drug addiction |
| 09/06/2007 | US20070208038 6-(2-Fluorophenyl)-Triazolopyrimidines, Method for Producing Them, Their use for Controlling Parasitic Fungi and Agents Containing the Same |
| 09/06/2007 | US20070208037 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
| 09/06/2007 | US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/06/2007 | US20070208035 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 09/06/2007 | US20070208034 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
| 09/06/2007 | US20070208033 Amine compound and use thereof |
| 09/06/2007 | US20070208032 Chemical compounds |
| 09/06/2007 | US20070208031 Substituted Diketopiperazines as Oxytocin Antagonists |
| 09/06/2007 | US20070208030 Tetrahydroindolone Derivatives for Treament of Neurological Conditions |
| 09/06/2007 | US20070208029 Modulation of neurogenesis by pde inhibition |
| 09/06/2007 | US20070208028 Administering metabotropic glutamate receptor antagonists, such as phenylethynylpyrimidines and phenylethynylpyrazines, to treat anxiety, epilepsy, schizophrenia, other psychotic disorder, Parkinson's disease, or addictive disorder |
| 09/06/2007 | US20070208027 Intermediate compounds for the manufacture of fused piperazin-2-one derivatives |
| 09/06/2007 | US20070208026 N-Containing Heteroaromatic Compounds As Modulators Of Ppars And Methods Of Treating Metabolic Disorders |
| 09/06/2007 | US20070208025 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 09/06/2007 | US20070208024 (3-Fluoro-4'-methanesulfonyl-biphenyl-4-yl)-[2-(S)-(2-(R)-methyl-pyrrolidin-1-ylmethyl)-pyrrolidin-1-yl]-methanone; treatment of obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases |
| 09/06/2007 | US20070208023 Cancer Treatment Method |
| 09/06/2007 | US20070208022 Hiv inhibiting 5-carbo- or heterocyclyl substituted pyrimidines |
| 09/06/2007 | US20070208021 Phenoxyacetic Acid Derivatives and Drug Comprising The Same |
| 09/06/2007 | US20070208020 P70S6 Kinase Modulators And Method Of Use |
| 09/06/2007 | US20070208019 Vasculostatic agents and methods of use thereof |
| 09/06/2007 | US20070208018 Quinazoline Derivatives |
| 09/06/2007 | US20070208017 e.g. 3-(3-{[7-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}-amino)heptyl]oxy}propyl)benzenesulfonamide triphenylacetate; beta 2-adrenoreceptors stimulant, bronchodilator; reversible airways obstruction: asthma, chronic obstructive pulmonary disease (COPD), respiratory tract infection |
| 09/06/2007 | US20070208016 1-(3-tert-butyl-4-methoxy-5-morpholinophenyl)-2-(5,6-diethoxy-7-fluoro-1-imino-1,3-dihydroisoindol-2-yl)ethanone,; stabilizing the composition; not decompose even when placed under humidification conditions |
| 09/06/2007 | US20070208015 5-Morpholinylmethylthiophenyl Pharmaceutical Compounds As P38 MAP Kinase Modulators |
| 09/06/2007 | US20070208014 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 09/06/2007 | US20070208013 Pyrrolotriazine Derivatives Useful For Treating Hyper-Proliferative Disorders And Diseases Associated With Angiogenesis |
| 09/06/2007 | US20070208011 Supersaturated Benzodiazepine Solutions and Their Delivery |
| 09/06/2007 | US20070208010 {(1R)-1-(2,4,5-Trifluorobenzyl)-2-[9-(trifluoromethyl)-5,6-dihydrobis[1,2,4]triazolo[1,5-a:3',4'-c]pyrazin-3-yl]ethyl}amine, hydrochloride; metformin; treating non-insulin dependent (Type 2) diabetes in a mammal |
| 09/06/2007 | US20070208009 Combination of anti-hiv reverse transcriptase and protease inhibitors |
| 09/06/2007 | US20070208008 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 09/06/2007 | US20070208007 Amine-Based Compound and Use Thereof |
| 09/06/2007 | US20070208006 For treatment of behavioral disorders associated with dementia, psychoses |
| 09/06/2007 | US20070208005 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h3 receptor |
| 09/06/2007 | US20070208004 Indol-1-yl-acetic acid derivatives |
| 09/06/2007 | US20070208003 Compounds and methods for treating dyslipidemia |
| 09/06/2007 | US20070208002 Method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms |
| 09/06/2007 | US20070208001 Modulators of 11- beta hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same |
| 09/06/2007 | US20070208000 smooth muscle/non-muscle myosin activator without changing the calcium transient; cardiac sarcomere modulators; to treat systolic heart failure like congestive heart failure; methyl 1-(3-((4-(ethylsulfonyl)piperazin-1-yl)methyl)-2-fluorophenyl)-3-(6-methylpyridin-3-yl)urea;substituted urea derivatives |
| 09/06/2007 | US20070207999 New Compounds |
| 09/06/2007 | US20070207998 Muscarinic Antagonists With Parp and Sir Modulating Activity as Agents for Inflammatory Diseases |
| 09/06/2007 | US20070207997 inhibitors of I kappa B kinase ( IKK-2) 2-amino-9-methyl-9H-pyrido[2,3-b]indole-3-carboxamide, useful for treating inflammatory diseases and cancer |
| 09/06/2007 | US20070207996 Novel Compositions And Methods Of Treatment |
| 09/06/2007 | US20070207995 Deazapurines useful as inhibitors of Janus kinases |
| 09/06/2007 | US20070207994 3-Phenyl-pyrazole derivatives as modulators of the 5-HT2a serotonin receptor useful for the treatment of disorders related thereto |
| 09/06/2007 | US20070207993 Molybdenum carbonyl complexes for treating rheumatoid arthritis and other inflammatory diseases |
| 09/06/2007 | US20070207992 Geldanamycin derivatives and method of use thereof |
| 09/06/2007 | US20070207991 Substituted N-aryl Heterocycles, Process For Their Preparation and Their Use As Medicaments |
| 09/06/2007 | US20070207990 Process for the preparation of phenylcarbamates |
| 09/06/2007 | US20070207989 Diterpene derivatives for the treatment of cardiovascular, cancer and inflammatory diseases |
| 09/06/2007 | US20070207988 Topical skin care composition |
| 09/06/2007 | US20070207986 Delivering modified inositol hexaphosphate (IHP); enhance the ability of mammalian red blood cells to deliver oxygen, by delivering IHP to the cytoplasm of the red blood cells; cardiovascular and respiratory disorders |
| 09/06/2007 | US20070207985 treating diabetes, hyperglycemia, obesity, dyslipidemia, and hypertension; compounds are based on 1,2,4-triazine and fused ring derivatives thereof, for example 3-Adamantan-1-yl-5,6-dimethyl-1,2,4-triazine |
| 09/06/2007 | US20070207984 Cyclohexylamino Benzene, Pyridine, and Pyridazine Derivatives |
| 09/06/2007 | US20070207983 Use of Sphingolipids in the Treatment and Prevention of Type 2 Diabetes Mellitus, Insulin Resistance and Metabolic Syndrome |
| 09/06/2007 | US20070207982 17-phosphorous steroid derivatives useful as progesterone receptor modulators |
| 09/06/2007 | US20070207980 Chp-gemcitabine Combination Agents And Their Use As Anti-Tumor Agents |
| 09/06/2007 | US20070207979 Method of using adenosine receptor blockers during tissue ablation |
| 09/06/2007 | US20070207978 Stimulate mammalian coronary vasodilatation; imaging the heart; antiinflammatory; adjunctive therapy with angioplasty; platelet aggregation inhibitor; inhibitor of platelet and neutrophil activation; |
| 09/06/2007 | US20070207977 Naphthalimide compositions and uses thereof |
| 09/06/2007 | US20070207976 Nucleic acids and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 09/06/2007 | US20070207975 Materials and methods for treating and preventing Her-2/neu overexpressing, FAS-elevated cancer cells |
| 09/06/2007 | US20070207973 1,3,5-Triazines for Treatment of Viral Diseases |
| 09/06/2007 | US20070207972 Macrolide antibiotics; active against Macrolides-Lincosamides-type B Streptogramines; reduction, chlorination, |
| 09/06/2007 | US20070207971 Neuraminidase inhibitor |
| 09/06/2007 | US20070207970 Use Of L-Carnitine For The Treatment Of Cardiovascular Diseases |
| 09/06/2007 | US20070207968 Peptidomimetic Inhibitors Of Retroviral Proteases And Their Use As Antivirals |
| 09/06/2007 | US20070207964 Combined use of a GLP-1 compound and another drug for treating dyslipidemia |
| 09/06/2007 | US20070207957 Composition For Accelerating Alcohol Metabolism Or Relieving Fatigue By Gluconeogenesis |
| 09/06/2007 | US20070207950 Methods and compositions for regulating HDAC6 activity |
| 09/06/2007 | US20070207946 Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels |
| 09/06/2007 | US20070207945 Extended cycle multiphasic oral contraceptive method |
| 09/06/2007 | US20070207930 Rhamnolipid compositions and related methods of use |
| 09/06/2007 | US20070207541 Method of prevention of lysosomal leakage in eukaryotic cells by using 6-methyluracil based water-soluble compounds and method of producing thereof |
| 09/06/2007 | US20070207523 Mammalian t-type calcium channels |
| 09/06/2007 | US20070207509 Zinc-based screening test and kit for early diagnosis of prostate cancer |
| 09/06/2007 | US20070207486 determining whether a patient will respond to anti-VEGF antibody based chemotherapy by screening suitable cell or tissue sample from the patient for at least one genomic polymorphism or genotype; using a bevacizumab antibody or an antibody that binds to the same epitope on VEGF and and cyclophosphamide |
| 09/06/2007 | US20070207462 Preventive/Remedy for Respiratory Diseases |
| 09/06/2007 | US20070207434 Methods and systems for concurrent tooth repositioning and substance delivery |
| 09/06/2007 | US20070207231 Composition and use of phyto-percolate for treatment of disease |
| 09/06/2007 | US20070207229 Inhibitor of blood glucose level elevation and inhibitor of age generation comprising acerola leaf extract and food product comprising either thereof |
| 09/06/2007 | US20070207228 Composition for Regulating the Trophism of Hair Follicles and the Cutaneous Production of Sebum and Use Thereof in Androgenic Alopecia |
| 09/06/2007 | US20070207227 Appetite suppressant compositions |
| 09/06/2007 | US20070207226 Composition for enhancing muscle mass development in animals |
| 09/06/2007 | US20070207225 Genistein modulated reduction of cardiovascular risk factors |
| 09/06/2007 | US20070207224 From soybeans; crystallization; menopause; strong estrogenic activity toward human cells; includes genistein, daidzein and glyciten; bioassay |
| 09/06/2007 | US20070207218 Combinations of vanadium with antidiabetics for glucose metabolism disorders |
| 09/06/2007 | US20070207217 Method for treating a mammal by administration of a compound having the ability to release CO |
| 09/06/2007 | US20070207216 Flavored colonic cleansing system |
| 09/06/2007 | US20070207214 Oral pharmaceutical compositions with controlled release and prolonged absorption |
| 09/06/2007 | US20070207208 Compositions and Methods Using a Cardiac Glycoside |
| 09/06/2007 | US20070207207 Bioadhesive drug formulations for oral transmucosal delivery |
| 09/06/2007 | US20070207206 Chewable pain formula |
| 09/06/2007 | US20070207205 Rapidly Disintegrating Taste-Masked Tablet |